Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3275 Target Snapshot

NAD-dependent histone deacetylase SIR2 · SINGLE PROTEIN · Saccharomyces cerevisiae S288c

98Compounds
27Assays
0Approved Drugs
54.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P06700. Use UniProt P06700 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P06700 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats NAD-dependent histone deacetylase SIR2 as ChEMBL target CHEMBL3275, mapped to UniProt P06700. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
NAD-dependent histone deacetylase SIR2
SINGLE PROTEIN · Saccharomyces cerevisiae S288c
As of 2026-09-14
ChEMBL target ID
CHEMBL3275
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P06700
NAD-dependent histone deacetylase SIR2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether NAD-dependent histone deacetylase SIR2 is the right protein anchor across sources, using UniProt P06700 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNAD-dependent histone deacetylase SIR2
UniProt AccessionP06700
Component TypeProtein
Sequence Length562 aa

NAD-dependent histone deacetylase SIR2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as NAD-dependent histone deacetylase SIR2, mapped to UniProt P06700. Sequence length is 562 aa.

Mapped IDP06700
Review nameNAD-dependent histone deacetylase SIR2
OrganismSaccharomyces cerevisiae S288c
Assay Mix

Activity Type Distribution

IC5054.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL316059 5.06 IC50 8800.0 Preclinical
CHEMBL313393 4.92 IC50 12000.0 Preclinical
CHEMBL314311 4.6 IC50 25000.0 Preclinical
CHEMBL313293 4.57 IC50 27000.0 Preclinical
CHEMBL88683 4.57 IC50 27000.0 Preclinical
CHEMBL91134 4.57 IC50 27000.0 Preclinical
CHEMBL372375 4.48 IC50 33000.0 Preclinical
CHEMBL88830 4.41 IC50 39000.0 Preclinical
CHEMBL327644 4.39 IC50 41000.0 Preclinical
CHEMBL315508 4.37 IC50 43000.0 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
0
5.5
0
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

27
Total Assays
33
Tested Compounds
2
Assay Types
Binding — 26 assays, 33 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 26 33 4.3
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine